Notices

Nagase Diagnostics Co., Ltd. Receives Technology Award at the 65th Annual Meeting of the Japan Society of Clinical Chemistry

Nagase Diagnostics Co., Ltd. is proud to announce that we have received the Technology Award at the 65th Annual Meeting of the Japan Society of Clinical Chemistry (JSCC), held on November 7–9, 2025. This award recognizes our achievement in developing a standardized glycated albumin (GA) assay kit and our contribution to standardization.
GA is increasingly recognized worldwide as a relevant biomarker for intermediate-term glycemic control in people with diabetes.
Nagase Diagnostics Co., Ltd. has been committed to developing the GA assay kit that complies with standardization requirements and participating in standardization activities. These efforts help ensure consistency and reliability in clinical measurements, supporting improved diabetes care through GA standardization. This award acknowledges the significance of these ongoing efforts.

About the Standardized Glycated Albumin (GA) Assay Kit
What is Glycated Albumin (GA)?
What is Standardization?
About Nagase Diagnostics